- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Artificial Intelligence and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Geneviève Michaux
Events 13 results
Conference
November 7, 2023
Pharmaceutical University 2023
Conference
September 7, 2023
16th Annual King & Spalding Medical Device Summit
Speaking Engagement
September 7, 2023
King & Spalding’s Cross-Disciplinary Life Sciences Team to Present on AI at the 16th Annual Medical Device Summit
Webinar
April 20, 2023
Revision of the EU Pharmaceutical Legislation - What To Expect
Conference
November 1, 2022
Pharmaceutical University 2022
Webinar
September 21, 2022
Regulation of Cell and Gene Therapies – Part 2: EU Law
Speaking Engagement
June 14, 2022
Geneviève Michaux to Speak at Global Biologics Cell and Gene Legal Conference
Speaking Engagement
Speaking Engagement
March 17, 2022
Geneviève Michaux to Speak at Annual Conference on EU Law in the Pharmaceutical Sector 2022
Webinar
November 9, 2021
King & Spalding Pharmaceutical University 2021
Webinar
September 9, 2021
14th Annual King & Spalding Medical Device Summit